Prothena Corp. Plc (PRTA)
9.50
+0.15
(+1.60%)
USD |
NASDAQ |
Sep 01, 14:54
Prothena Total Long Term Debt (Quarterly) : 4.03M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.03M |
| March 31, 2026 | 4.761M |
| December 31, 2025 | 5.487M |
| September 30, 2025 | 6.203M |
| June 30, 2025 | 6.928M |
| March 31, 2025 | 7.575M |
| December 31, 2024 | 8.233M |
| September 30, 2024 | 8.881M |
| June 30, 2024 | 9.538M |
| March 31, 2024 | 10.12M |
| December 31, 2023 | 10.72M |
| September 30, 2023 | 8.918M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 1.649M |
| June 30, 2022 | 3.278M |
| March 31, 2022 | 4.834M |
| December 31, 2021 | 6.386M |
| September 30, 2021 | 7.922M |
| June 30, 2021 | 9.426M |
| March 31, 2021 | 10.88M |
| December 31, 2020 | 12.33M |
| September 30, 2020 | 13.75M |
| June 30, 2020 | 15.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.50M |
| December 31, 2019 | 17.84M |
| September 30, 2019 | 19.16M |
| June 30, 2019 | 20.45M |
| March 31, 2019 | 21.70M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Alkermes Plc | 1.565B |
| Amarin Corp. Plc | 5.255M |
| Agenus, Inc. | 259.00M |
| Amgen, Inc. | 57.30B |
| Anika Therapeutics, Inc. | 23.32M |